"beta-Thalassemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent.
| Descriptor ID |
D017086
|
| MeSH Number(s) |
C15.378.071.141.150.875.150 C15.378.420.826.150 C16.320.070.875.150 C16.320.365.826.150
|
| Concept/Terms |
beta-Thalassemia- beta-Thalassemia
- Microcytemia, beta Type
- Microcytemias, beta Type
- Type Microcytemia, beta
- Type Microcytemias, beta
- beta Type Microcytemia
- beta Type Microcytemias
- beta Thalassemia
- Thalassemia, beta
- Thalassemias, beta
- beta Thalassemias
- Thalassemia, beta Type
- Thalassemias, beta Type
- Type Thalassemia, beta
- Type Thalassemias, beta
- beta Type Thalassemia
- beta Type Thalassemias
Thalassemia Intermedia- Thalassemia Intermedia
- Intermedia, Thalassemia
- Intermedias, Thalassemia
- Thalassemia Intermedias
Thalassemia Minor- Thalassemia Minor
- Thalassemia Minor (beta-Thalassemia Minor)
- Minor, Thalassemia (beta-Thalassemia Minor)
- Minors, Thalassemia (beta-Thalassemia Minor)
- Thalassemia Minor (beta Thalassemia Minor)
- Thalassemia Minors (beta-Thalassemia Minor)
Thalassemia Major- Thalassemia Major
- Anemia, Erythroblastic
- Anemias, Erythroblastic
- Erythroblastic Anemia
- Thalassemia Major (beta-Thalassemia Major)
- Major, Thalassemia (beta-Thalassemia Major)
- Majors, Thalassemia (beta-Thalassemia Major)
- Thalassemia Major (beta Thalassemia Major)
- Thalassemia Majors (beta-Thalassemia Major)
- Mediterranean Anemia
- Anemias, Mediterranean
- Mediterranean Anemias
- Anemia, Cooley's
- Anemia, Cooley
- Anemia, Cooleys
- Cooley's Anemia
- Anemia, Mediterranean
|
Below are MeSH descriptors whose meaning is more general than "beta-Thalassemia".
Below are MeSH descriptors whose meaning is more specific than "beta-Thalassemia".
This graph shows the total number of publications written about "beta-Thalassemia" by people in this website by year, and whether "beta-Thalassemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "beta-Thalassemia" by people in Profiles.
-
Digital thermography and vascular involvement in ?-thalassemia intermedia. Ann Hematol. 2021 Oct; 100(10):2471-2477.
-
The Spectrum of ?-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study. Hemoglobin. 2021 Nov; 45(6):365-370.
-
A Fatal Case of Necrotizing Pancreatitis in Sickle Cell Beta Thalassemia Zero. Am Surg. 2018 Sep 01; 84(9):e401-e402.
-
Thrombin generation and cell-dependent hypercoagulability in sickle cell disease. J Thromb Haemost. 2016 10; 14(10):1941-1952.
-
Priapism, an emerging complication in ?-thalassemia intermedia patients. Hemoglobin. 2014; 38(5):351-4.
-
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov; 88(11):E255-60.
-
Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
-
Measurement and correction of stimulated echo contamination in T2-based iron quantification. Magn Reson Imaging. 2013 Jun; 31(5):664-8.
-
Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate. NMR Biomed. 2011 Aug; 24(7):771-7.
-
Vascular at-risk genotypes and disease severity in Lebanese sickle cell disease patients. Am J Hematol. 2010 May; 85(5):395-6.